Microarray agreement combines award-winning DualChip microarray offerings from Eppendorf with PerkinElmer's high-performance scanner to deliver optimum systems in microarray applications
PerkinElmer and Eppendorf have signed a co-marketing agreement to jointly promote microarray technology that combines Eppendorf's DualChip content arrays with PerkinElmer's ScanArray GX microarray analysis system.
The announcement was made at the Chips to Hits industry event being held 12-14 September 2005, in Boston.
The combination of the novel DualChip technology, consisting of two identical arrays on a single slide, and the user-friendly scanning protocols of ScanArray GX provides a complete system, from array processing to data analysis, the companies say.
The PerkinElmer/Eppendorf microarray solution is described as ideal for a wide range of applications, including medical, clinical and biotechnology research.
"Our scanners, combined with the optimised protocols for Eppendorf's new chip technologies, will deliver reliability and simplicity to customers," said Peter Coggins, president, PerkinElmer Life and Analytical Sciences.
"For each DualChip, Eppendorf will provide exact protocols to allow customers to set-up and optimise their assays on PerkinElmer scanners, thereby offering considerable advantages and significantly increasing efficiency".
"With PerkinElmer and Eppendorf's combined array expertise, committed scientists can now use an array as a personal tool that fits the budget," stated Thomas Kolzau, director of the microarray systems product group at Eppendorf.
Only recently Eppendorf had been conferred the 2005 Frost and Sullivan Technology Innovation Award in recognition for its unique contribution by proactively leveraging its new DualChip microarray technology to molecular technologies towards possible drug discovery and clinical research applications.
According to Frost and Sullivan's findings, microarrays have been widely demonstrated to empower researchers working in drug discovery and clinical research through the expression profiling method.